How to Read a COA and HPLC Report for Tirzepatide Lots
A procurement checklist for labs sourcing RUO incretin material — what to verify before you run metabolic assays.
Read article →Research Blog
Industry updates, peptide science notes, and laboratory procurement guides.
GLP-1 Research Supply After the 2022–2024 Incretin Surge
Why hospital shortages created bench demand — and how laboratories should source RUO material without grey-market risk.
Read article →Retatrutide Has a Public Sequence — Your Lab Still Needs a Trusted Lot
Why patent disclosure does not replace COA-backed identity for triple-agonist research material.
Read article →Modeling Post-Menopausal Metabolic Shift With Incretin Tools
How endocrine labs frame GLP-1 / GIP research around estrogen decline and visceral adiposity — without patient marketing.
Read article →Storing Lyophilized Research Peptides in the Laboratory
Cold-chain and stability practices for RUO vials in cell-culture and animal-facility workflows — not personal use.
Read article →Why Top Independent Stations Publish COA — And How to Copy That Trust Model
Lessons from high-converting research catalogs on transparency, cap coding, and batch documentation.
Read article →